| Net Cash Provided by (Used in) Operating Activities |
$146,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,087,000,000 |
USD |
-196% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$563,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
124,064,321 |
shares |
0.49% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$6,606,000,000 |
USD |
17% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$6,000,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,000,000 |
USD |
0% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$3,699,000,000 |
USD |
8.3% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,074,000,000 |
USD |
-40% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,004,000,000 |
USD |
8.6% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
70,100 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$1,000,000 |
USD |
-95% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$13,893,000,000 |
USD |
-0.43% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
70,100 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$3,698,000,000 |
USD |
8.3% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |